超声乳化联合人工晶体植入术治疗年龄相关性白内障合并糖尿病的临床研究  被引量:9

Clinical Research the Treatment of Phacoemulsification and Iol Implantation in Age-related Cataract of Diabetes Mellitus

在线阅读下载全文

作  者:凌宇[1] 梁日雄[1] 唐彦慧[1] 何正端[1] 唐琪[1] 

机构地区:[1]南宁市第一人民医院,广西南宁530022

出  处:《中国医学创新》2017年第5期130-133,共4页Medical Innovation of China

摘  要:目的:分析总结合并有糖尿病的年龄相关性白内障治疗中超声乳化联合人工晶体植入术的应用价值。方法:将2015年1月-2016年3月就诊,合并有糖尿病的102例(133眼)年龄相关性白内障患者作为观察对象,按照随机数字表法将患者分为两组,其中对照组51例(66眼)接受小切口白内障摘除及人工晶体植入术,观察组51例(67眼)接受超声乳化联合人工晶体植入术。对两组治疗效果进行比较。结果:两组治疗前后角膜散光度及BCVA均为上升趋势(P<0.05);同时,虽然治疗前及术后1周时,两组角膜散光度、BCVA比较,差异均无统计学意义(P>0.05),但在术后1、3个月时,观察组角膜散光度及BCVA均明显高于对照组(P<0.05)。同时,在随访期间内,两组术后并发症发生率比较,差异无统计学意义(P>0.05)。此外,年龄与治疗前后角膜散光度差值及治疗前后BCVA差值均呈显著的负向直线相关性(P<0.05)。结论:超声乳化联合人工晶体植入术可在不增加治疗并发症的同时有效提高临床治疗效果,且其治疗效果与患者年龄密切相关。Objective: To analyze and summarize the application value of phacoemulsification and iol implantation in age-related cataract of diabetes mellitus.Method: From January 2015 to March 2016, 102 cases ( 133 eyes ) with diabetes age-related cataract patients were selected as research objects.The patients were divided into two groups at random, 51 cases of the control group ( 66 eyes )accepted small incision cataract extraction and iol implantation, the observation group of 51 cases ( 67 eyes ) accepted phacoemulsification and iol implantation. The differences and treatment effect between two groups were analyzed.Result: There was rising trend of corneal scattered luminosity and BCVA before and after the treatment of two groups ( P〈0.05 ) .At the same time, although there were no statistical differences of c0meal scattered luminosity and BCVA between two groups before and after 1 week treatment ( P〉O.05 ), but 1 month after surgery and postoperative 3 months, corneal scattered luminosity and BCVA of the Observation group were obviously higher than those of the control group ( P〈0.05 ) .At the same time,during the period of follow-up, there was no statistical difference of incidence between two groups ( P〉0.05 ) .In addition, there was negative linear correlation between age and the corneal scattered photometric difference before and after treatment and BCVA (P〈0.05) .Conclusion: Phacoemulsification and iol implantation can effectively improve the clinical therapeutic effect, and its treatment effect is closely related to patients age.

关 键 词:超声乳化 人工晶体植入术 年龄 白内障 糖尿病 

分 类 号:R779.66[医药卫生—眼科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象